The stock rallied 11.6% following the quarter, driven by robust revenue growth and margin expansion that surpassed investor expectations, signaling strong operational execution and favorable mix dynamics.

• Total revenue grew 26% year-over-year to $3.6 billion, with Pharmacy Solutions and Provider Services up 25% and 28%, respectively.
• Adjusted EBITDA increased 45% to $190 million, with margins expanding by 70 basis points to 5.3%, primarily due to mix improvements and operational efficiencies.
• Operating cash flow reached $123 million, excluding proceeds from the recent Community Living divestiture.
• Leverage improved significantly to 2.27x from 2.99x, supported by $811 million in cash proceeds from the divestiture used for debt reduction.
• High service quality metrics sustained, including over 91% of Home Health branches rated 4 stars or greater and top-tier hospice program rankings.